Cargando…
Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the pr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546325/ https://www.ncbi.nlm.nih.gov/pubmed/23325989 http://dx.doi.org/10.4103/0250-474X.103839 |
_version_ | 1782256035222781952 |
---|---|
author | Bajpai, M. Singh, D. C. P. Bhattacharya, A. Singh, A. |
author_facet | Bajpai, M. Singh, D. C. P. Bhattacharya, A. Singh, A. |
author_sort | Bajpai, M. |
collection | PubMed |
description | In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the present work was to develop pulsatile release tablet of losartan potassium for chronotherapy in hypertension. The prepared system consisted of a core tablet coated with versatile and safe hydrophilic cellulosic ethers such as, hydroxypropyl methylcellulose, hydroxypropyl cellulose and sodium carboxy methylcellulose to produce burst release after predetermined lag time. Various formulation factors were studied through series of test and in vitro dissolution study. It was found that core tablets containing superdisintegrant failed to produce burst drug release pattern while effervescent agent was able to do so. Results also reveal that coating composition and coating level affects lag time. Formulation containing effervescent agent in core and coated with 200 mg hydroxypropyl cellulose provide lag time of 4.5 h with 73% drug release in 6 h that followed a sigmoidal release pattern. These values were close to the desired objective of producing lag time of 5-6 h followed by fast drug release. This approach can thus provide a useful means for timed release of losartan and is helpful for patients with morning surge. |
format | Online Article Text |
id | pubmed-3546325 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35463252013-01-16 Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium Bajpai, M. Singh, D. C. P. Bhattacharya, A. Singh, A. Indian J Pharm Sci Research Paper In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the present work was to develop pulsatile release tablet of losartan potassium for chronotherapy in hypertension. The prepared system consisted of a core tablet coated with versatile and safe hydrophilic cellulosic ethers such as, hydroxypropyl methylcellulose, hydroxypropyl cellulose and sodium carboxy methylcellulose to produce burst release after predetermined lag time. Various formulation factors were studied through series of test and in vitro dissolution study. It was found that core tablets containing superdisintegrant failed to produce burst drug release pattern while effervescent agent was able to do so. Results also reveal that coating composition and coating level affects lag time. Formulation containing effervescent agent in core and coated with 200 mg hydroxypropyl cellulose provide lag time of 4.5 h with 73% drug release in 6 h that followed a sigmoidal release pattern. These values were close to the desired objective of producing lag time of 5-6 h followed by fast drug release. This approach can thus provide a useful means for timed release of losartan and is helpful for patients with morning surge. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3546325/ /pubmed/23325989 http://dx.doi.org/10.4103/0250-474X.103839 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Bajpai, M. Singh, D. C. P. Bhattacharya, A. Singh, A. Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title | Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title_full | Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title_fullStr | Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title_full_unstemmed | Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title_short | Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium |
title_sort | design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546325/ https://www.ncbi.nlm.nih.gov/pubmed/23325989 http://dx.doi.org/10.4103/0250-474X.103839 |
work_keys_str_mv | AT bajpaim designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium AT singhdcp designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium AT bhattacharyaa designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium AT singha designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium |